← All patents

US12171803B2

Methods of CD40 and toll like receptor immune activation

University of Texas System

Abstract

Provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of a TLR agonist and a chimeric CD154 polypeptide. Also provided herein are methods of enhanced immune function.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Willem OVERWIJK
Priority date
April 12, 2017
Filing date
April 11, 2018
Grant date
December 24, 2024
Publication date
December 24, 2024
Language
en
Metadata fetched
August 29, 2026 00:32